The Fund Grade · free · no account needed
What grade does CFIMX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Clipper Fund
#457 of 500 graded active funds · value · large segment peer group
The point · specialist footprint
CFIMX puts less of its book behind proven specialists than 60% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
CFIMX vs the Honor Roll · share card ↗Conviction exposure
19.5%
of the book in specialist-converged names
Late-stage weight
19.6%
of the book in Crowded or Fading names
Active share
94.9%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Clipper Fund grades F, ranked 457 out of 500, with only 19.5% specialist ownership and five positions where specialists are actively leaving, including CVS, Tyson Foods, and Cigna. The fund does show early specialist interest in USB and Viatris, but nearly 20% of the portfolio sits in late or crowded stages. Three higher graded peers exist in the same segment.
→ Watch CVS, Tyson Foods, and Cigna closely, as specialists are fading from all three, which together represent over 10% of the fund.
→ Compare this fund against the three higher graded segment peers, since the F grade and low specialist backing argue for a close look at alternatives.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.